Phase III anti-HIV microbicide trial in Africa and India stopped as preliminary results show gel may increase risk of infection
Editorial team, Collective, Weekly releases (1997–2007), 12, 3137 (2007), https://doi.org/10.2807/esw.12.06.03137-en